QQQ   303.25 (-0.07%)
AAPL   122.84 (+0.10%)
MSFT   213.88 (-1.08%)
FB   288.05 (+0.52%)
GOOGL   1,825.32 (+1.67%)
AMZN   3,211.98 (-0.25%)
TSLA   560.60 (-4.13%)
NVDA   541.93 (+1.18%)
BABA   261.77 (-0.85%)
CGC   28.25 (+6.00%)
GE   10.38 (+2.27%)
MU   68.68 (+2.39%)
AMD   94.53 (+2.05%)
T   28.93 (+0.21%)
NIO   46.25 (+1.96%)
F   9.19 (-0.54%)
ACB   10.99 (+12.72%)
NFLX   503.52 (-0.21%)
BA   218.52 (+2.59%)
GILD   61.43 (+0.51%)
DIS   152.18 (+1.83%)
QQQ   303.25 (-0.07%)
AAPL   122.84 (+0.10%)
MSFT   213.88 (-1.08%)
FB   288.05 (+0.52%)
GOOGL   1,825.32 (+1.67%)
AMZN   3,211.98 (-0.25%)
TSLA   560.60 (-4.13%)
NVDA   541.93 (+1.18%)
BABA   261.77 (-0.85%)
CGC   28.25 (+6.00%)
GE   10.38 (+2.27%)
MU   68.68 (+2.39%)
AMD   94.53 (+2.05%)
T   28.93 (+0.21%)
NIO   46.25 (+1.96%)
F   9.19 (-0.54%)
ACB   10.99 (+12.72%)
NFLX   503.52 (-0.21%)
BA   218.52 (+2.59%)
GILD   61.43 (+0.51%)
DIS   152.18 (+1.83%)
QQQ   303.25 (-0.07%)
AAPL   122.84 (+0.10%)
MSFT   213.88 (-1.08%)
FB   288.05 (+0.52%)
GOOGL   1,825.32 (+1.67%)
AMZN   3,211.98 (-0.25%)
TSLA   560.60 (-4.13%)
NVDA   541.93 (+1.18%)
BABA   261.77 (-0.85%)
CGC   28.25 (+6.00%)
GE   10.38 (+2.27%)
MU   68.68 (+2.39%)
AMD   94.53 (+2.05%)
T   28.93 (+0.21%)
NIO   46.25 (+1.96%)
F   9.19 (-0.54%)
ACB   10.99 (+12.72%)
NFLX   503.52 (-0.21%)
BA   218.52 (+2.59%)
GILD   61.43 (+0.51%)
DIS   152.18 (+1.83%)
QQQ   303.25 (-0.07%)
AAPL   122.84 (+0.10%)
MSFT   213.88 (-1.08%)
FB   288.05 (+0.52%)
GOOGL   1,825.32 (+1.67%)
AMZN   3,211.98 (-0.25%)
TSLA   560.60 (-4.13%)
NVDA   541.93 (+1.18%)
BABA   261.77 (-0.85%)
CGC   28.25 (+6.00%)
GE   10.38 (+2.27%)
MU   68.68 (+2.39%)
AMD   94.53 (+2.05%)
T   28.93 (+0.21%)
NIO   46.25 (+1.96%)
F   9.19 (-0.54%)
ACB   10.99 (+12.72%)
NFLX   503.52 (-0.21%)
BA   218.52 (+2.59%)
GILD   61.43 (+0.51%)
DIS   152.18 (+1.83%)
Log in
ASX:VTI

Visioneering Technologies, Inc. (VTI.AX) Stock Forecast, Price & News

Add
Compare
Today's Range N/A
50-Day Range N/A
52-Week Range N/A
VolumeN/A
Average VolumeN/A
Market CapitalizationN/A
P/E RatioN/A
Dividend YieldN/A
BetaN/A
Visioneering Technologies, Inc., a medical device company, engages in the design, manufacture, sale, and distribution of contact lenses. The company offers NaturalVue, a contact lense for adults with presbyopia and children with myopia. It operates in the United States, Australia, New Zealand, Europe, Hong Kong, and Singapore. The company was founded in 2008 and is headquartered in Alpharetta, Georgia.

Beat the Market (BTM) Rank™

Analyst Opinion: 0.0Community Rank: 0.0Dividend Strength: 0.0Insider Behavior: 1.7Valuation: 0.0 5 -4 -3 -2 -1 -

Overall Beat the Market Rank™

0.33 out of 5 stars


Industry, Sector and Symbol

Stock Exchange ASX
Industry Medical Devices
Sub-IndustryN/A
SectorMedical
Current SymbolASX:VTI
Previous Symbol
CUSIPN/A
CIKN/A
Webwww.vtivision.com
Phone844-884-5367
EmployeesN/A

Debt

Debt-to-Equity Ratio288.77
Current Ratio6.61
Quick Ratio4.86

Price-To-Earnings

Trailing P/E RatioN/A
Forward P/E RatioN/A
P/E GrowthN/A

Sales & Book Value

Annual Sales$5.44 million
Price / Sales0.00
Cash FlowN/A
Price / Cash FlowN/A
Book ValueA$0.00 per share
Price / BookN/A

Profitability

EPS (Most Recent Fiscal Year)N/A
Net IncomeN/A
Net MarginsN/A
Return on EquityN/A
Return on AssetsN/A

Miscellaneous

Outstanding SharesN/A
Market CapN/A
Next Earnings DateN/A
OptionableOptionable

Receive VTI News and Ratings via Email

Sign-up to receive the latest news and ratings for VTI and its competitors with MarketBeat's FREE daily newsletter.

speech bubbles
speech bubbles











Visioneering Technologies, Inc. (VTI.AX) (ASX:VTI) Frequently Asked Questions

What stocks does MarketBeat like better than Visioneering Technologies, Inc. (VTI.AX)?

Wall Street analysts have given Visioneering Technologies, Inc. (VTI.AX) a "N/A" rating, but there may be better short-term opportunities in the market. Some of MarketBeat's winning trading ideas this year have resulted in 5-15% weekly gains. MarketBeat just released five new trading ideas, but Visioneering Technologies, Inc. (VTI.AX) wasn't one of them. MarketBeat thinks these five stocks may be even better buys.
View MarketBeat's top stock picks here.

Who are some of Visioneering Technologies, Inc. (VTI.AX)'s key competitors?

Some companies that are related to Visioneering Technologies, Inc. (VTI.AX) include Adherium Limited (ADR.AX) (ADR), ADM Tronics Unlimited (ADMT), ADM Tronics Unlimited (ADMT), Allegra Orthopaedics Limited (AMT.AX) (AMT), ALR Technologies (ALRT), Analytica Limited (ALT.AX) (ALT), AnteoTech Limited (ADO.AX) (ADO), Atomo Diagnostics Limited (AT1.AX) (AT1), AVITA Therapeutics, Inc. (AVH.AX) (AVH), Azure Healthcare Limited (AZV.AX) (AZV), Cannabix Technologies (BLO), Cochlear (CHEOY), Cochlear (CHEOF), Cochlear Limited (COH.AX) (COH) and Cyclopharm Limited (CYC.AX) (CYC).
View all competitors.

Who are Visioneering Technologies, Inc. (VTI.AX)'s key executives?

Visioneering Technologies, Inc. (VTI.AX)'s management team includes the following people:
  • Dr. Stephen Snowdy, CEO & Exec. Director (Age 50, Pay $498.98k)
  • Mr. Brian D. Lane CPA, Chief Financial Officer (Age 58, Pay $328.07k)
  • Mr. Tony Sommer Jr., Sr. VP of Sales & Marketing
  • Dr. Richard A. Griffin, Founder & Medical Adviser
  • Ms. Leanne Ralph BBus, ACIS, AAICD, Company Sec.
  • Ms. Layna L. Mendlinger, Exec. Director of Marketing
  • Dr. Douglas P. Benoit OD, FAAO, Exec. Director of Professional Affairs

What is Visioneering Technologies, Inc. (VTI.AX)'s stock symbol?

Visioneering Technologies, Inc. (VTI.AX) trades on the ASX under the ticker symbol "VTI."

How big of a company is Visioneering Technologies, Inc. (VTI.AX)?

Visioneering Technologies, Inc. (VTI.AX) has a market capitalization of $0.00 and generates $5.44 million in revenue each year.

What is Visioneering Technologies, Inc. (VTI.AX)'s official website?

The official website for Visioneering Technologies, Inc. (VTI.AX) is www.vtivision.com.

How can I contact Visioneering Technologies, Inc. (VTI.AX)?

The company can be reached via phone at 844-884-5367.

This page was last updated on 12/2/2020 by MarketBeat.com Staff
Receive Analysts' Upgrades and Downgrades Daily

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.